COVID-19 Vaccine Update: Novavax starts phase I/II clinical trials, here’s all you need to know about the vaccine

Named NVX‑CoV2373, Novavax’s vaccine is created using recombinant protein nanoparticle technology.


The post COVID-19 Vaccine Update: Novavax starts phase I/II clinical trials, here’s all you need to know about the vaccine appeared first on Firstpost.

Comments

Popular posts from this blog

India’s first quarter GDP growth likely to be weakest since 2012; coronavirus, lockdown halted economic activity: Poll